TRIM TO 1% BOOK WEIGHT; HOLD TRIGGERS AT $106.24 TO ADD ON VOLUME BREAKOUT OR $82.40 TO EXIT FURTHER

• INTC trades at 47.5x forward earnings with TTM profit margin of -19.8%, meaning the +315% twelve-month return has already priced in the recovery thesis—buying here is the "last leg" of multiple expansion that has already occurred
• Altera catalyst represents only 1-2% of the $513 billion market cap ($5-10 billion) versus $30 billion liquidity and $50 billion total debt; the +315% run has this optionality already baked in
• With beta of 2.23, INTC amplifies market moves 2.2x in an environment where 10-year is at 19-year high, oil above $100, Fed has 94% probability of zero cuts in 2026, and recession odds jumped 9 percentage points in one week—high-beta means asymmetric downside exposure
• The "coiled spring" technical setup shows the 50 SMA rolled from $117 to $97 over two months (decelerating medium-term trend), MACD at 0.54 is weakest possible bullish signal, and ATR compression at $97-$106 resistance often precedes disappointing expansion moves
• The aggressive analyst's $106/$120/$140 upside ladder stacks three bull cases (Altera at 2x revenue IPO, Fed dovish pivot September 16, Intel 18A marquee customer win) as base case, when base case should be hostile macro, conservative Altera multiples, AMD winning x86 sockets, Nvidia encroaching on adjacent processing, and Intel grinding sideways to lower
• Realistic base case downside is closer to $20-$25, not the stated $13.60, on a 4-5% position with 2.23 beta in this macro
• Moving from 2-3% to 4-5% book weight (50-100% exposure increase) at the 50 SMA after a +315% twelve-month run in hostile macro is "the textbook definition of buying tops"
• The conservative analyst recommends trimming to 1% rather than maintaining 2-3%, preserving capital and optionality to add on confirmed breakout above $106.24 with volume or exit below $82.40
• Discipline is not paralysis; the aggressive "don't wait, you'll miss it" framing is the same language used before every major drawdown; risk management's job is to say no when the room wants to add

→ vs aggressive: 47.5x forward earnings for a company with -19.8% TTM margin is not justified by an improving earnings stream—the multiple expansion has already happened during the +315% run, making this the "last leg" of a trade rather than the beginning

→ vs aggressive: Altera represents only 1-2% of market cap ($5-10 billion) versus $30 billion liquidity and $50 billion debt, a small catalyst with uncertain pricing that is already priced into the +315% run

→ vs aggressive: The macro "cuts both ways" framing is wrong—2.23 beta in a hostile macro (94% probability of zero Fed cuts, recession odds up 9 points) means asymmetric downside exposure, and "eventually improving macro" does not mean "you will be paid to wait"

→ vs aggressive: The "coiled spring" ATR compression reads as a coin flip with added high-beta risk; the 50 SMA roll from $117 to $97 shows medium-term deceleration, MACD at 0.54 is the weakest possible bullish signal, and compression at $97-$106 resistance often precedes disappointed bulls

→ vs aggressive: The upside ladder of $106/$120/$140 stacks three bull cases as base case; the realistic base case downside is $20-$25, not the stated $13.60, and the $10 upside versus $13.60 downside framing was generous to the bull case

→ vs aggressive: Adding 50-100% more exposure at 4-5% weight at the 50 SMA after a +315% twelve-month run is "the textbook definition of buying tops"—the same pattern seen before every major drawdown

→ vs aggressive: The "wait for confirmation" approach is not analysis paralysis but discipline; the aggressive "don't wait, you'll miss it" pitch is the exact language used at every bull market peak to justify adding

→ vs neutral: Maintaining 2-3% book weight is slightly too generous given the deteriorating macro and risk/reward; trimming to 1% preserves capital, locks in gains, and preserves optionality to add on confirmed technical breakout or macro turn

HOLD at 2-3% book weight with defined triggers: trim to 1% on close below $82.40 on volume, scale to 4% on close above $106.24 with above average volume sustained 2-3 sessions; do not add at current ~$97 level; re-evaluate after Q3 earnings.

• Q2 revenue growth of 25% and operating income swing from -$1.29B to +$1.97B represent genuine operational turnaround not a value trap
• TTM free cash flow of $4.87B and Q2 operating cash flow of $7B demonstrate real cash generation
• 47.5x forward earnings multiple with TTM profit margin of -19.8% has already priced in the recovery arc; multiple more likely to compress than expand
• Beta of 2.23 creates 2x amplifier on macro outcomes in environment of 19-year high 10-year yields, oil above $100, and recession odds up 9 percentage points in one week
• Lower high technical pattern ($142, $82, $106, $97) shows deteriorating structure despite long-term uptrend intact
• Altera S-1 filing on retained 49% FPGA stake is a real, dated catalyst with $5-10B NAV unlock potential (at 2x revenue multiples) representing asymmetric upside not fully priced
• ATR compression and positive MACD crossover indicate genuine equilibrium with slight upside lean based on catalyst stack
• AMD winning x86 sockets and Nvidia encroaching on adjacent processing is a structural overhang preventing multiple expansion to semiconductor leader levels
• Conservative trim to 1% into this catalyst window sells a probability-weighted setup with more upside than downside over next 4-6 weeks
• Macro is hostile today but not permanently hostile; yields cycle and recession odds can reverse quickly
• Current 2-3% weight appropriate given risk profile; position has meaningful upside catalyst exposure while preserving dry powder for clean breakout or meaningful drawdown

→ vs aggressive: Saying the multiple should expand from current 47.5x is not analysis, it is hope. The price has already moved to reflect the operational trajectory. The beta of 2.23 in a tightening cycle is a 2x amplifier on macro pain, not asymmetric upside. Catalyst stack (Altera at 2x revenue, Fed dovishness, Intel 18A wins) are all bull cases stacked and called base case—how you build a position that gets vaporized on first earnings disappointment

→ vs conservative: Trimming from 2-3% to 1% into this catalyst window locks in exposure to the downside while giving up asymmetric Altera optionality. The $5-10B NAV unlock from the 49% retained FPGA stake can re-rate the multiple by several turns even if magnitude is small relative to $513B market cap. Selling into positive MACD crossover and ATR compression is selling a setup with more upside than downside on probability-weighted basis over next 4-6 weeks